PMVP
Pmv Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.70 / 10
Netural
Liquidity flow evaluation: 7.4/10 demonstrating robust fund flow characteristics. Optimistic no significant trends patterns are mitigated by pessimistic overall, block, Small, Medium, Large, and Extra-large indicators, pointing to positive flow perspective. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-03-20
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for PMVP?
- PMVP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.70/10 (Netural).
